Condition guide
Breast cancer care in Canada is strong, and most people are best treated close to home. This page explains standard care and where China may add options for some people with advanced or recurrent breast cancer.
Breast cancer is the most common cancer in women in Canada, and men can develop it too. Most breast cancers are found at an early stage, when treatment works well.
Doctors test the tumour for hormone receptors (oestrogen and progesterone) and for a protein called HER2. These results divide breast cancer into groups, such as hormone receptor-positive, HER2-positive and triple-negative. Each group is treated differently.
Surgery is the main treatment for early breast cancer. It may remove part of the breast (lumpectomy) or the whole breast (mastectomy), along with some lymph nodes. Radiation, chemotherapy, hormone therapy and HER2-targeted drugs are added according to the tumour type and stage. Immunotherapy is used for some triple-negative cancers.
For cancer that has spread or come back, treatment aims to control it for as long as possible with a good quality of life. Options include hormone therapy with targeted drugs, chemotherapy, HER2-targeted treatment and antibody-drug conjugates, which carry chemotherapy straight to cancer cells. Several of these are already used in Canada. Clinical trials are worth asking about at any stage.
Newer medicines, such as a TROP2-targeted antibody-drug conjugate approved in China for some advanced triple-negative breast cancers after earlier treatment. Not approved in Canada or the US at the time of writing.
Read more →Gentle heating alongside radiotherapy, sometimes used for breast cancer that has come back on the chest wall. Not a stand-alone treatment, and evidence is limited.
Read more →Heat treatment occasionally used for a few small liver spots when the cancer is otherwise controlled. Evidence in breast cancer is limited.
Read more →Expert review of your pathology, receptor results and treatment history.
Read more →Breast nodule ablation is not a breast cancer treatment. It is offered only for nodules proven benign by biopsy, such as fibroadenomas. It must never be used for a lump that has not been biopsied or that could be cancer. We are still confirming which Chinese hospitals currently offer it to international patients.
The main reason is advanced breast cancer that has grown after the standard treatments available at home, when a medicine approved in China may match your tumour type. Some people with cancer that has returned on the chest wall after radiation also ask about hyperthermia. Others simply want a second view on their treatment plan.
A drug approved in China is not automatically better. Canada already uses a similar antibody-drug conjugate, and if you have had a drug from the same family, it is not well known how much a second one adds. Chinese hospitals decide whether they can accept you after reviewing your records. We cannot promise access or results.
Upload your reports and scans for specialist review.
Read more →What to ask for, and how to request it from your hospital.
Read more →Helpful questions before you decide on any travel.
Read more →No. It treats only benign nodules that a biopsy has shown are not cancer. It is not used for breast cancer and must never replace cancer care.
Usually not. Early breast cancer is treated very well in Canada, and surgery is part of a plan that continues with radiation or drug treatment at home. Splitting that plan across countries can cause delays.
Regulators work on their own timelines, and some drugs are developed by Chinese companies and tested first in China. Approval in China does not mean the drug has been compared with the best treatment available at home.
Often not simply. Importing unapproved medicines has legal limits, and ongoing supply can be difficult. We help you plan this before you commit. See our medicines guide.
Only after your records are reviewed and a Chinese team has agreed to see you. We share the hospital details then, and confirm them in writing before you book anything.
Do not delay or stop standard treatment while you explore options. Your oncologist at home should know about any plan. Licensed doctors make every treatment decision. We coordinate and do not promise outcomes.
Sources: Canadian Cancer Society, Treatments for breast cancer · Canadian Cancer Society, Treatments for triple-negative breast cancer · National Cancer Institute, Treatment for breast cancer · OncLive, Sacituzumab tirumotecan approved in China for pretreated advanced triple-negative breast cancer
Last reviewed: 12 November 2026. This page is general information, not medical advice.
Sino Health Link is an independent coordination service, not a hospital. We do not diagnose, prescribe or treat. Licensed doctors make all medical recommendations and decisions with you.
